INS and Insulin resistance: The results indicated that the MD led to lower blood-glucose levels at 6 months, compared with the control group [49], but there were no other associations or between-group differences with regards to high-density-lipoprotein cholesterol (HDL-C), low-density-lipoprotein cholesterol (LDL-C), total cholesterol, triacylglycerol, insulin or the homeostatic model assessment of insulin resistance (HOMA-IR) (Figure 2).